Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy

NCT01566292 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Enlargement (BPE)

Interventions

DRUG: BOTOX

Sponsor

Catholic University of the Sacred Heart